Je was op zoek naar: adenomatoziniu (Lithouws - Engels)

ilgalaikiu placebu kontroliuojamuju tyrimu duomenimis, 200 mg ir 400 mg celekoksibo doze du kartus per para vartojusiems asmenims, turejusiems pavieniu adenomatoziniu polipu, palyginti su
increased number of serious cardiovascular events, mainly myocardial infarction, has been found in a long-term placebo-controlled study in subjects with sporadic adenomatous polyps treated with celecoxib at doses of 200mg bid and 400mg bid compared to placebo (see 5.1).

gauti išankstiniai duomenys triju tebevykstanciu ilgalaikiu celekoksibo saugumo klinikiniu tyrimu, kuriuose dalyvauja ligoniai, turintys pavieniu storosios žarnos adenomatoziniu polipu arba predispozicija susirgti alzheimerio liga.
preliminary safety information from three long-term studies involving patients with sporadic adenomatous polyps or who were predisposed to developing alzheimer’ s disease treated with celecoxib is available.

naudojant gyvn seimins adenomatozins polipozs (fap) model, nustatyta, kad gydant kitais tiazolidindionais padidja naviko isplitimas storojoje zarnoje.
in an animal model of familial adenomatous polyposis (fap) , treatment with two other thiazolidinediones increased tumour multiplicity in the colon.